Studies that have assessed its expression in tumor samples, suggest the role of GRB7 as an adaptor protein that binds to tyrosine kinase receptors like HER2, to amplify its signal and mediate the activation of several downstream proteins involved in cell migration and survival pathways (45). Here, ERBB2 is linked to neoplasm.